About this Session:
In September, our esteemed colleagues at DTA held a Capitol Hill Advocacy Event to promote awareness and discuss policies and legislation that provide better access and coverage to DTx. Today, they share what they took away from those meetings and discuss the relevance of the Access to Prescription Digital Therapeutics Act of 2022. Moderator: Andy Molnar , CEO, Digital Therapeutics Alliance Panelists: Liesl Oldstone , VP, Health Economics and Market Access, AppliedVR Everett Crosland, Chief Commercial Officer, Cognito Therapeutics